New Olympus cellSens 2.1 speeds up image analysis

Helping drive research forward at a faster rate, Olympus cellSens 2.1 speeds up image analysis with improved capabilities for flexible camera and microscope control. The updates ensure cellSens remains a powerful tool covering a wide range of applications and benefiting routine microscopy users as well as advanced imaging facilities.

A fluorescent image shown before (left) and after (right) deconvolution with the image deconvolution module in cellSens 2.1.

With expanded imaging capabilities, Olympus has launched version 2.1 of its imaging platform cellSens. Enabling researchers to create clean and detailed images in less time, this latest version of cellSens delivers faster deconvolution and improved feature sets across all software levels.

Reaffirming cellSens’ position as an advanced, comprehensive solution for imaging facilities, cellSens Dimension and Standard now feature fully integrated multi-channel acquisition and support for the latest high-end devices. The capabilities of cellSens Entry have also been expanded so that all cellSens users can now manage encoded devices, perform measurements and export the results to Excel. Advanced imaging capabilities such as panoramic and extended depth-of-focus imaging are now also available to all users.

Important time savings can now be obtained if the application requires the creation of de-blurred fluorescence images. Deconvolution calculations exploit the processing power of modern graphics cards to obtain clean and precise images up to 7 times faster than before. Productivity and interactivity are greatly enhanced as, for example, a deconvolved image can now be obtained in 10 seconds instead of in one minute.

In addition, in order to facilitate the integration of cellSens into advanced imaging facilities even further, export functions have been made more flexible and powerful. Images are easily exported from cellSens in different file formats, including Open Microscopy Environment (OME), as single files or multiple files split according to external application need.

These advances in speed, functionality and compatibility make cellSens well suited for both routine and advanced research applications – underlining Olympus’ commitment to providing a flexible, user-friendly software platform that supports life science researchers everywhere.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Evident Corporation - Life Sciences. (2019, June 24). New Olympus cellSens 2.1 speeds up image analysis. News-Medical. Retrieved on July 13, 2024 from https://www.news-medical.net/news/20180620/New-Olympus-cellSens-21-speeds-up-image-analysis.aspx.

  • MLA

    Evident Corporation - Life Sciences. "New Olympus cellSens 2.1 speeds up image analysis". News-Medical. 13 July 2024. <https://www.news-medical.net/news/20180620/New-Olympus-cellSens-21-speeds-up-image-analysis.aspx>.

  • Chicago

    Evident Corporation - Life Sciences. "New Olympus cellSens 2.1 speeds up image analysis". News-Medical. https://www.news-medical.net/news/20180620/New-Olympus-cellSens-21-speeds-up-image-analysis.aspx. (accessed July 13, 2024).

  • Harvard

    Evident Corporation - Life Sciences. 2019. New Olympus cellSens 2.1 speeds up image analysis. News-Medical, viewed 13 July 2024, https://www.news-medical.net/news/20180620/New-Olympus-cellSens-21-speeds-up-image-analysis.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
AI-based pathology diagnosis tool in development detects 7 types of gastric cancer